Relative bioavailability study with Abediterol administered via three different inhalation devices in Healthy Volunteers.

Trial Identifier:	D6541C00001
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT04199598
Start Date:	January 2020
Primary Completion Date:	April 2020
Condition:	Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	German Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Berlin, Germany, 14050

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.